America's Best Nonprofits
  1. Home
  2. Philanthropy & Grantmaking
  3. Cherry Hill, NJ
  4. Dravet Syndrome Foundation

Dravet Syndrome Foundation

Dravet Syndrome Foundation is ranked among philanthropy & grantmaking organizations in Cherry Hill, NJ, with an America's Best Score of 81 out of 100, based on its 2024 Form 990.

  • Cherry Hill, NJ
  • Tax-exempt since 2010
  • EIN: 27-0924627
dravetfoundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
81OF 100 Ranked in Cherry Hill Philanthropy & Grantmaking How this score is calculated

Organization summary

Dravet Syndrome Foundation is a 501(c)(3) organization, classified under Philanthropy & Grantmaking (NTEE T30). Contributions are tax-deductible.

Po Box 3026, Cherry Hill, NJ 08034-0272

In fiscal year 2024 it reported $4,221,622 in revenue and $4,259,172 in expenses, with contributions making up 73.6% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

The mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families. We understand the ongoing need to fund innovative research, the urgency in finding better treatments, the motivation of our donors to make an impact specifically in the fields of Dravet syndrome and related epilepsies, the importance of transparency and accountability of not only our organization, but the researchers that we fund, and the need for global collaboration in order to find a cure.

Largest programs · fiscal year 2024

  • DSF funds research for better treatments and a cure for Dravet syndrome and related epilepsies by awarding research grants to qualified scientists and clinicians. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Since 2… Read more

    DSF funds research for better treatments and a cure for Dravet syndrome and related epilepsies by awarding research grants to qualified scientists and clinicians. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Since 2009, DSF has awarded over $10.5 million to 71 research endeavors. Research areas include SUDEP, gene therapy, drug discovery, screening, treatments, genetics, epidemiology and neuronal networks. DSF has also supported the development of a commercial line of iPSC cells for researchers and the biotechnology industry. DSF's Scientific Director serves as the liaison between the medical/scientific community and DSF, developing strategies to support research, manage DSF's involvement in projects, and move projects forward with assistance in project management, manuscript preparation, and other writing opportunities. The Scientific Director acts as a representative of DSF to other institutions including NIH, FDA, pharma and biotechnology companies.

    $2,672,460 spent · 74.2% of program spending
  • Receiving a diagnosis of Dravet syndrome (DS) can be overwhelming, leaving families with many unanswered questions. To support our patient community, DSF provides a variety of educational, advocacy, and support resources: These initiatives are part of DSF's commitment to providing vital resources and fostering a strong, supportive community for those affected by Dravet syndrome. DSF Family Network… Read more

    Receiving a diagnosis of Dravet syndrome (DS) can be overwhelming, leaving families with many unanswered questions. To support our patient community, DSF provides a variety of educational, advocacy, and support resources: These initiatives are part of DSF's commitment to providing vital resources and fostering a strong, supportive community for those affected by Dravet syndrome. DSF Family Network: Open to any parent, legal guardian, or sibling interested in our advocacy services and programs, the Family Network keeps members informed about new advocacy tools, clinical trials, educational opportunities, and fundraising events. It also includes moderated private Facebook support groups for parents and caregivers of individuals with Dravet syndrome. Membership is limited to those legally responsible for making medical decisions for the patient. In 2024, 347 people joined the Family Network. Newly Diagnosed Kits: DSF provides newly diagnosed families with a kit that includes a guidebook for navigating life after diagnosis, a medication bag, and other materials to ensure they have the knowledge and tools needed for their child's care. In 2024, DSF distributed 131 kits. Patient Assistance Grants: The DSF Patient Assistance Grant Program offers financial support to patients with Dravet syndrome and related SCN1A epilepsies for medical equipment, therapy devices, and educational aids not covered by private insurance or other programs. This program is available to all patients worldwide who are members of the DSF Family Network. Since 2009, DSF has awarded $279,000 to 249 families. Birthday Buddies: Families can register their loved one with Dravet syndrome to receive a birthday card and small gift from DSF's mascot, Aurora, around their birthday. In 2024, DSF sent 640 gifts. Super Siblings Club: DSF provides a day camp at our biennial conference and annual Day of Dravet workshops for siblings of individuals with Dravet syndrome. These events offer a fun and supportive environment for siblings to connect, express their feelings, and bond with others facing similar challenges. Bereavement Support: Losing a loved one, especially a child, is profoundly painful. DSF offers resources for coping with grief, including a Bereavement Support Group and Remembrance Wall. Legislative Advocacy Program: We are committed to keeping our patient community informed about legislative actions affecting Medicaid and rare disease research, which are essential for maintaining access to care and driving advancements in treatment for Dravet syndrome. By ensuring our constituents have accurate and nonpartisan information, they can advocate for their loved one and family effectively. Biennial Conference: This 3-day event brings together families, caregivers, clinicians, researchers, and pharmaceutical professionals to collaborate on improving the lives of those with Dravet syndrome. The conference features presentations on the latest research and patient care, fostering new relationships and collaborations. Over 500 people attended the 2024 conference. Day of Dravet Workshops: Held in alternating years from the biennial conference, these workshops offer families the opportunity to learn about research, treatment options, and connect with others. Sessions are led by community experts, including fellow parents. The workshops also include our VIP Sib Camp and activities for patients. In 2023, over 500 attendees participated at workshops in Colorado (Denver), Florida (Sanford), Connecticut (Stamford), California (Anaheim), and Kentucky (Newport).

    $764,750 spent · 21.2% of program spending
  • DSF produces an annual research roundtable meeting to provide opportunity for researchers and clinicians to collaborate and discuss better treatment options and a roadmap toward a cure and how to best facilitate both. This meeting started in 2010 as a brainstorming session for the few researchers working on Dravet syndrome. DSF hosted its 15th annual Research Roundtable with nearly 190 participants. $165,700 spent · 4.6% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 85¢ went to programs, 9¢ to management and 6¢ to fundraising.

  • Programs $3,602,910
  • Management $418,901
  • Fundraising $237,361

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score81 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves19.7 mo; 5.9 mo in cash13.7 / 25
Financial balance (median margin)+24.0%17.4 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+44.9% / yr15 / 15
Track record16 years6.4 / 10
Debt load18.3% of assets8.3 / 10
Total80.7 → 81
Spending on programs
Not scored; America's Best needs 65%+
85%Meets

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$4,221,622Fiscal year 20242022: $2,515,78220222023: $3,257,09620232024: $4,221,6222024
Expenses$4,259,172Fiscal year 20242022: $2,028,83920222023: $2,163,05220232024: $4,259,1722024
Total assets$8,536,916Fiscal year 20242022: $6,249,14820222023: $7,509,90220232024: $8,536,9162024
Total liabilities$1,560,863Fiscal year 20242022: $488,37420222023: $595,16620232024: $1,560,8632024
Fiscal year ending December 2024
Revenue$4,221,622
Expenses$4,259,172
Net income−$37,550
Net assets$6,976,053

Notable sources of revenue

Percent of total revenue
Contributions$3,106,931
Program services$734,789
Investment income$304,376
Other (net)$75,526

Assets / debt

Total assets$8,536,916
Total liabilities$1,560,863
Net assets$6,976,053

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$3,257,096
Expenses$2,163,052
Net income$1,094,044
Net assets$6,914,736

Notable sources of revenue

Percent of total revenue
Contributions$2,530,133
Program services$471,472
Investment income$218,414
Other (net)$37,077

Assets / debt

Total assets$7,509,902
Total liabilities$595,166
Net assets$6,914,736

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$2,515,782
Expenses$2,028,839
Net income$486,943
Net assets$5,760,774

Notable sources of revenue

Percent of total revenue
Contributions$1,713,227
Program services$662,596
Investment income$88,364
Other (net)$51,595

Assets / debt

Total assets$6,249,148
Total liabilities$488,374
Net assets$5,760,774

Compensation

Officers and key employees$243,560
Share of expenses12.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?